DIN 02529602 — MYXREDLIN 1 UNIT
MYXREDLIN is a solution of Insulin (Regular, Biosynthetic Human) marketed by BAXTER CORPORATION. The full Insulin (Regular, Biosynthetic Human) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02529602
- Brand name
- MYXREDLIN
- Active ingredient
- Insulin (Regular, Biosynthetic Human)
- Strength
- 1 UNIT
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BAXTER CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Short-acting (regular) human insulin (antidiabetic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.